A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults
- Journal:
- Journal of Infectious Diseases
- Published:
- Affiliations:
- 4
- Authors:
- 4
| Institutions | Authors | Share |
|---|---|---|
| The University of Iowa (UI), United States of America (USA) | 0.50 | |
| Baylor College of Medicine (BCM), United States of America (USA) | 0.25 | |
| Emory University, United States of America (USA) | 0.25 |